ResearchMoz

Computational Biology (Pharmacodynamics, Cellular Modeling, Computational Genomics, Proteomics, Pharmacogenomics, Pharmacokinetics, Human Simulation Software, Drug Discovery & Development) Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 - 2018

Transparency Market Research
Published Date » 2013-05-07
No. Of Pages » 112
   
 The computational biology market is predicted to have a notable growth owing to its wide use by biotechnology and pharmaceutical companies to reduce the incidences of late stage failures of their drugs and to thereby curb R&D expenditure. Computational biology is also assisting in reducing the extensive use of humans in trials and is therefore useful for pediatric trials, trials on pregnant women and orphan disease research. 
   
 This report analyses the global market for computational biology by two main types of studies-cellular modeling and disease modeling. Each of these segments has been further analyzed by various studies with use of simulation, right from drug discovery to drug development. The market has also been bifurcated on the basis of tools which include...
Table of Content

Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Scope Of The Report
1.4 Research Methodology
1.4.1 Sources
1.4.1.1 Secondary Research
1.4.1.2 Primary Research
1.4.1.3 Models
1.5 Assumptions

Chapter 2 Executive Summary
2.1 Market Snapshot: Global Computational Biology Market (2011 & 2018)
2.2 Global Computational Biology Market, by Types, 2011 (USD Million)

Chapter 3 Global Computational Biology Market Dynamics
3.1 Market Overview
3.2 Drivers
3.2.1 Failure Of Drug Candidates in Late Stage of Clinical Trials
3.2.1.1 Average Cost to Develop One New Drug (1975 -2011) (USD Million)
3.2.1.2 Trend of Rise in Failure of Phase II Clinical Trials (2006- 2012)
3.2.1.3 Reasons For Failure (%) in Phase II & Phase III
3.2.2 Enhanced Computational Tools
3.2.3 Improved Government Funding &Industrial Support
3.3 Restraints
3.3.1 Lack of Standardization
3.3.2 Non-Verified Predictive Models
3.4 Challenges
3.4.1 Shortage of Skilled Resources
3.4.2 Data Storage
3.5 Opportunities
3.5.1 Cloud Computing
3.5.2 Modelling And Simulations in Paediatrics Drug Development
3.6 Porters Five Forces Analysis
3.6.1 Bargaining Power of Suppliers
3.6.2 Bargaining Power of Buyers
3.6.3 Threat of New Entrants
3.6.4 Threat Of Substitutes
3.6.5 Competitive Rivalry
3.7 Market Attractiveness Analysis
3.7.1 Market Attractiveness Analysis: Global Computational Biology Market, by Geography
3.8 End User Analysis
3.8.1 End User Analysis: Global Computational Biology Market, 2011 & 2018 (%)

Chapter 4 Global Computational Biology Market, by Applications
4.1 Introduction
4.1.1 Cellular Modelling and Simulation
4.1.1.1 Computational Genomics
4.1.1.1.1 Global Computational Genomics Market Revenues, 2010 – 2018 (USD Million)
4.1.1.2 Computational Proteomics
4.1.1.2.1 Global Computational Proteomics Market Revenues, 2010 – 2018 (USD Million)
4.1.1.3 Pharmacogenomics
4.1.1.3.1 Global Computational Pharmacogenomics Market Revenues, 2010 – 2018 (USD Million)
4.1.1.4 Others (Metabolomics/ Transcriptomics)
4.1.1.4.1 Global Computational Others (Metabolomics/Transcriptomics) Market Revenue, 2010 – 2018 (USD Million)
4.1.2 Disease Modelling And Simulation Applications / CADD (Computer Aided Drug Design)
4.1.2.1 Drug Discovery
4.1.2.1.1 Global Computational Drug Discovery Market Revenues, 2010 – 2018 (USD Million)
4.1.2.1.2 Target Identification
4.1.2.1.2.1 Global Computational Target Identification Market Revenues, 2010 – 2018 (USD Million)
4.1.2.1.3 Target Validation
4.1.2.1.3.1 Global Computational Target Validation Market Revenues, 2010 – 2018 (USD Million)
4.1.2.1.4 Lead Identification/Discovery
4.1.2.1.4.1 Global Computational Lead Identification Market Revenues, 2010 – 2018 (USD Million)
4.1.2.1.5 Lead Optimization
4.1.2.1.5.1 Global Computational Lead Optimization Market Revenues, 2010 – 2018 (USD Million)
4.1.2.1 Drug Development
4.1.2.1.1 Preclinical
4.1.2.1.1.1 Global Computational Preclinical Trials Market Revenues, 2010 – 2018 (USD Million)
4.1.2.1.2 Clinical Trials
4.1.2.1.2.1 Global Computational Clinical Trials Market Revenues, 2010 – 2018 (USD Million)
4.1.2.1.2.2 Phase I
4.1.2.1.2.3 Global Computational Clinical Trials Phase I Market Revenues, 2010 – 2018 (USD Million)
4.1.2.1.2.4 Phase II
4.1.2.1.2.5 Global Computational Clinical Trials Phase II Market Revenues, 2010 – 2018 (USD Million)
4.1.2.1.2.6 Phase III
4.1.2.1.2.7 Global Computational Clinical Trials Phase III Market Revenues, 2010 – 2018 (USD Million)
4.1.2.1.3 Human Body Simulation Software
4.1.2.1.3.1 Global Computational Human Simulation Software Market Revenues, 2010 – 2018 (USD Million)

Chapter 5 Global Computational Biology Market, by Tools
5.1 Overview
5.2 Database
5.2.1 Global Computational Biology Database Market Revenues, 2010 – 2018 (USD Million)
5.3 IT Infrastructure (Hardware)
5.3.1 Global Computational Biology Hardware Market Revenues, 2010 – 2018 (USD Million)
5.4 Analysis Software & Services
5.4.1 Global Computational Biology Software Market Revenues, 2010 – 2018 (USD Million)

Chapter 6 Global Computational Biology Market, by Services
6.1 Overview
6.2 In-House Computational Biology
6.2.1 Global In-House Computational Biology Market Revenues, 2010 – 2018 (USD Million)
6.3 External/Contract Computational Biology
6.3.1 Global Contract Computational Biology Market Revenues, 2010 – 2018 (USD Million)

Chapter 7 Global Computational Biology Market, by Geography
7.1 Overview
7.2 North America
7.2.1 North America Computational Biology Market Revenues, 2010 – 2018 (USD Million)
7.3 Europe
7.3.1 Europe Computational Biology Market Revenues, 2010 – 2018 (USD Million)
7.4 Asia
7.4.1 Asia Computational Biology Market Revenues, 2010 – 2018 (USD Million)
7.5 ROW
7.5.1 Row Computational Biology Market Revenues, 2010 – 2018 (USD Million)

Chapter 8 Market Share Analysis
8.1 Market Share by Key Players
8.1.1 Global Computational Biology Market Share Analysis of Key Players, 2011 (%)

Chapter 9 Recommendations
9.1 Success Strategies
9.1.1 Rigorous Research and Development (R&D) Initiatives
9.1.2 Investing in Emerging Economies
9.1.3 Investing in High-End Technologies
9.1.4 Collaborations, Mergers and Acquisitions
9.2 Barriers to be Considered
9.2.1 High Cost of Investment

Chapter 10 Company Profiles
10.1 Accelrys
10.1.1 Company Overview
10.1.2 Financial Overview
10.1.3 Product Portfolio And Services
10.1.4 Business Strategy
10.1.5 Recent Developments
10.2 Certara
10.2.1 Company Profile
10.2.2 Financial Overview
10.2.3 Product Portfolio And Services
10.2.4 Business Strategy
10.2.5 Recent Developments
10.3 Chemical Computing Group Inc.
10.3.1 Company Profile
10.3.2 Financial Overview
10.3.3 Product Portfolio
10.3.4 Business Strategy
10.3.5 Recent Developments
10.4 Compugen, Ltd
10.4.1 Company Profile
10.4.2 Financial Overview
10.4.3 Business Strategy
10.4.4 Recent Developments
10.5 Entelos
10.5.1 Company Profile
10.5.2 Financial Overview
10.5.3 Product Portfolio And Services
10.5.4 Business Strategy
10.5.5 Recent Developments
10.6 Genedata AG
10.6.1 Company Profile
10.6.2 Financial Overview
10.6.3 Product Portfolio And Services
10.6.4 Business Strategy
10.6.5 Recent Developments
10.7 Insilico Biotechnology AG
10.7.1 Company Profile
10.7.2 Financial Overview
10.7.3 Product Portfolio
10.7.4 Business Strategy
10.7.5 Recent Developments
10.8 Leadscope, Inc
10.8.1 Company Profile
10.8.2 FinancialOverview
10.8.3 Product Portfolio
10.8.4 Business Strategy
10.8.5 Recent Developments
10.9 Nimbus Discovery LLC
10.9.1 Company Profile
10.9.2 Financial Overview
10.9.3 Product Portfolio
10.9.4 Business Strategy
10.9.5 Recent Developments
10.10 RhenoviaPharma SAS
10.10.1 Company Profile
10.10.2 Financial Overview
10.10.3 Product Portfolio And Services
10.10.4 Business Startegy
10.10.5 Recent Developments
10.11 Schrodinger
10.11.1 Company Overview
10.11.2 Financial Overview
10.11.3 Product Portfolio And Services
10.11.4 Business Strategy
10.11.5 Recent Developments
10.12 Simulation Plus, Inc.
10.12.1 Company Profile
10.12.2 Financial Overview
10.12.3 Product Portfolio And Services
10.12.4 Business Strategy
10.12.5 Recent Developments

List of Tables

List of Tables

TABLE 1 Global Computational Biology Market: Snapshot (2011 & 2018)
TABLE 2 R&D Function by Expenditure (%)
TABLE 3 Global Computational Biology Market Revenues, by Segments, 2010 – 2018 (USD Million)
TABLE 4 Global Cellular Modeling and Biology Simulation Market Revenues, by Types, 2010 – 2018 (USD Million)
TABLE 5 Global Cellular Modeling and Biology Simulation Market Revenues, by Geography, 2010 – 2018 (USD Million)
TABLE 6 Global Disease Modeling and Simulation Market Revenues, by Types, 2010 - 2018 (USD Million)
TABLE 7 Global Disease Modeling and Simulation Market Revenues, by Geography, 2010 - 2018 (USD Million)
TABLE 8 Global Computational Drug Development Market Revenues, by Types, 2010 - 2018 (USD Million)
TABLE 9 Software Packages for PBPK Modeling
TABLE 10 Global Computational Biology Market Revenues, by Tools, 2010- 2018 (USD Million)
TABLE 11 Global Computational Services Market Revenues, by Services, 2010- 2018 (USD Million)
TABLE 12 Global Computational Biology Market, by Geography, 2010- 2018 (USD Million)

List of Figures

List of Figures

FIG. 1 Global Computational Biology: Market Segmentation
FIG. 2 Global Computational Biology Market, By Types, 2011 (USD Million)
FIG. 3 Average Cost to Develop one New Drug (1975 -2011) (USD Million)
FIG. 4 Trend of Rise in Failure of Phase II Clinical Trials (2006- 2012)
FIG. 5 Reasons for Failure (%) in Phase II & Phase III
FIG. 6 Porter’s Five Forces Analysis for Computational Biology Market
FIG. 7 Market Attractiveness Analysis: Global Computational Biology Market, By Geography
FIG. 8 End User Analysis: Global Computational Biology Market, 2011 & 2018 (%)
FIG. 9 Global Computational Genomics Market Revenues, 2010 – 2018 (USD Million)
FIG. 10 Global Computational Proteomics Market Revenues, 2010 – 2018 (USD Million)
FIG. 11 Global Computational Pharmacogenomics Market Revenues, 2010 – 2018 (USD Million)
FIG. 12 Global Computational Others (Metabolomics/ Transcriptomics) Market Revenue, 2010 – 2018 (USD Million)
FIG. 13 Global Computational Drug Discovery Market Revenues, 2010 – 2018 (USD Million)
FIG. 14 Global Computational Target Identification Market Revenues, 2010 – 2018 (USD Million)
FIG. 15 Global Computational Target Validation Market Revenues, 2010 – 2018 (USD Million)
FIG. 16 Global Computational Lead Identification Market Revenues, 2010 – 2018 (USD Million)
FIG. 17 Global Computational Lead Optimization Market Revenues, 2010 – 2018 (USD Million)
FIG. 18 Global Computational Preclinical Trials Market Revenues, 2010 – 2018 (USD Million)
FIG. 19 Global Computational Clinical Trials Market Revenues, 2010 – 2018 (USD Million)
FIG. 20 Global Computational Clinical Trials Phase I Market Revenues, 2010 – 2018 (USD Million)
FIG. 21 Global Computational Clinical Trials Phase II Market Revenues, 2010 – 2018 (USD Million)
FIG. 22 Global Computational Clinical Trials Phase III Market Revenues, 2010 – 2018 (USD Million)
FIG. 23 Global Computational Human Simulation Software Market Revenues, 2010 – 2012 (USD Million)
FIG. 24 Global Computational Biology Database Market Revenues, 2010 – 2018 (USD Million)
FIG. 25 Global Computational Biology Hardware Market Revenues, 2010 – 2018 (USD Million)
FIG. 26 Global Computational Biology Software Market Revenues, 2010 – 2018 (USD Million)
FIG. 27 Global In-House Computational Biology Market Revenues, 2010 – 2018 (USD Million)
FIG. 28 Global Contract Computational Biology Market Revenues, 2010 – 2018 (USD Million)
FIG. 29 North America Computational Biology Market Revenues, 2010 – 2018 (USD Million)
FIG. 30 Europe Computational Biology Market Revenues, 2010 – 2018 (USD Million)
FIG. 31 Asia Computational Biology Market Revenue, 2010 – 2018 (USD Million)
FIG. 32 Row Computational Biology Market Revenues, 2010 – 2018 (USD Million)
FIG. 33 Global Computational Biology Market Share Analysis Of Key Players, 2011 (%)
FIG. 34 Annual Revenues: Accelrys, 2009 - 2011 (USD Million)
FIG. 35 Annual Revenue: Compugen, 2010 – 2012 (USD Million)
FIG. 36 Annual Revenues: Simulation Plus, Inc., 2010 – 2012 (USD Million)

Upcoming Reports:

Paclitaxel Injection Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2013 - 2019
By - Transparency Market Research
Paclitaxel injection is a viscous anticancer drug, derived from the bark of the Pacific yew tree. Paclitaxel belongs to the group of drugs called antineoplastic. Paclitaxel injection is primarily used to treat various advanced stage cancer of the breast,ovaries, Kaposi sarcoma and non-small cell lung cancer. It is type of cytoskeletal medication that targets tubulin, which are a type of globular proteins. The body cells that have defects in chromosome segregation, mitotic spindle assembly and cell division are treated Paclitaxel. Paclitaxel works by inhibiting the growth of cancer cells...
Poland: milk market
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the milk market in Poland and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the milk market in Poland, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an elaborate overview of the main market...
Propionaldehyde Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
By - Transparency Market Research
Propionaldehyde, also known as propanol, is a colorless liquid with a fruity odor. Propionaldehyde is an organic compound and is an isomer of acetone. Propionaldehyde is mainly used in the production of cosmetics, personal care products and basic chemicals. The application products of propionaldehyde are used in several end-user industries such as chemicals, home and personal care and pharmaceuticals. In the chemicals industry, propionaldehyde is used for manufacturing basic chemicals, organic chemicals, agricultural chemicals, pesticides and fertilizers. In the home and personal care...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Hitachi Readies New Suite of Driving Systems
Oct 16, 2014  
Japan’s Hitachi Automotive Systems is all set to unveil a line of innovative autonomous driving technologies as the trend of high-tech and automotive electronics takes the industry by storm. The suite of technologies were unveiled in northern Japan last week and included features such as no-hands self-parking, vehicle stability control in electric automobiles, precrash braking, and...
Canadas Agreement on Waste-Water Treatment Boosts Indias PM Pet Clean Ganga Project
Oct 16, 2014  
In 2008, Canada and India adopted a bilateral science and technology collaboration agreement for Scientific and Technological Cooperation.  The pet Clean Ganga project led by the Indian Prime Minister Narendra Modi has received a confident boost with an agreement earlier on Wednesday. The agreement is all about cleaning up the most heavily used river in the world between Canada...
China Sends Experimental Ebola Drugs to Aid Workers, to Increase Supply if Found Effective
Oct 16, 2014  
An experimental Ebola drug has been sent to Africa for use by Chinese aid worker by a Chinese drug manufacturer. The company is plans to undertake clinical trials of the drug to combat the deadly Ebola outbreak in West Africa that has claimed more than 4000 lives so far. Several thousand doses of the drug JK-05, manufactured by Sihuan Pharmaceutical Holdings Group Ltd, have been...
Broccoli Based Chemical Gives Hope For Treating Autism
Oct 15, 2014  
According to the inferences derived from a small scale clinical trial, the chemical that is extracted from the sprouts of broccoli possess certain anti-cancerous properties. Moreover, this chemical may be able to even treat behavioral symptoms in those suffering from autism spectrum disorders. This research study was carried out by the scientists of Johns Hopkins University School of Medicine...
Toyota China to Recall Crown Sedans Due to Leaking Brake Fluid Issue
Oct 15, 2014  
Joining the global wave of automobile recalls, Toyota has announced its decision to recall 93,700 cars from the Chinese market to fix an issue regarding leaking brake fluid, Chinese quality watchdog has informed.  Tianjin FAW Toyota Motor Co, the Chinese subsidiary of Toyota Motor Corp., will recall the Crown model sedans manufactured by it between 1st December 2009 and 14th June 2012....